Jeffrey A Meckler's Net Worth
Jeffrey A Meckler's net worth is estimated to be at least $1,085,196.49 as of 11/23/2024. CoreStreet's estimation of Jeffrey A Meckler's net worth is based on their sale of stock and current holding of stock.
Jeffrey A Meckler is Director at Travere Therapeutics Inc. They have executed at least 9 trades of stock as per SEC Form 4 filings. Their most recent trade was for 40,000 units of TVTX stock on 09/30/2024. Their biggest sale was on 09/30/2024 when they sold 40,000 units of Travere Therapeutics Inc stock for $562,400.00. They typically trade 1 times per year.
Total value of insider buys:
- $522,796.49
Total value of insider sells:
- $562,400.00
Most recent insider trade:
- Sept. 30, 2024
Jeffrey A Meckler's Insider Trading History
Travere Therapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Sept. 30, 2024 | Director | 40,000 | $14.06 | Sell | $562,400.00 |
Indaptus Therapeutics Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Nov. 21, 2022 | CEO | 9,600 | $1.90 | Buy | $18,240.00 |
Nov. 18, 2022 | CEO | 400 | $1.76 | Buy | $704.00 |
Sept. 8, 2022 | CEO | 10,308 | $2.80 | Buy | $28,862.40 |
June 6, 2022 | CEO | 19,727 | $2.63 | Buy | $51,882.01 |
Nov. 18, 2021 | CEO | 11,187 | $5.82 | Buy | $65,108.34 |
Cocrystal Pharma Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
March 15, 2016 | CEO | 294,118 | $0.51 | Buy | $150,000.18 |
Dec. 23, 2015 | CEO | 100,000 | $0.58 | Buy | $58,000.00 |
March 25, 2015 | Director | 163,043 | $0.92 | Buy | $149,999.56 |